Diagnostic Co. Investors Try To Seal $2.1M Stock-Drop Deal
Investors in Meridian Bioscience Inc. on Monday asked an Ohio federal judge for approval of a $2.1 million settlement that resolves their claims that some of the company's medical diagnostic kits...To view the full article, register now.
Already a subscriber? Click here to view full article